Rewriting endogenous human transcripts with dual CRISPR-guided 3′ trans-splicing
Cell Systems · 2026
DOI: 10.1016/j.cels.2025.101487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2026. Verfasst von Sita S Chandrasekaran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Arc Institute, 3181 Porter Drive, Palo Alto, CA 94304, USA; Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA; Univ…. Hauptthemen laut MEDLINE: Trans-Splicing, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Arc Institute, Siebel Scholars Foundation, Shurl and Kay Curci Foundation.
Abstract (Originalsprache)
Unlike genome editing, RNA editing offers the ability to transiently alter cells with minimal risk from off-target effects. While exon-skipping technologies can influence splice site selection, many desired perturbations to the transcriptome require replacement or addition of exogenous exons to target mRNAs, such as replacing disease-causing exons, repairing truncated proteins, or engineering protein fusions. Here, we report the development of RNA-guided trans-splicing with Cas editor (RESPLICE). RESPLICE uses two orthogonal RNA-targeting CRISPR effectors to co-localize a trans-splicing pre-mRNA and to inhibit the cis-splicing reaction, respectively. We demonstrate efficient, specific, and programmable trans-splicing of RNA cargo (up to 2.1 kb) into 11 endogenous transcripts across 3 cell types, achieving up to 45% trans-splicing efficiency in bulk or 90% when sorting for high effector expression. Our results present RESPLICE as a mode of RNA editing that could provide fine-tuned and transient control of cellular programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Arc Institute, 3181 Porter Drive, Palo Alto, CA 94304, USA; Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA; University of California, Berkeley, San Francisco Graduate Program in Bioe…
- Arc Institute, 3181 Porter Drive, Palo Alto, CA 94304, USA; Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
- Arc Institute, 3181 Porter Drive, Palo Alto, CA 94304, USA.
- Arc Institute, 3181 Porter Drive, Palo Alto, CA 94304, USA; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: silvana@arcinstitute.org.
- Arc Institute, 3181 Porter Drive, Palo Alto, CA 94304, USA; Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA; Center for Computational Biology, University of California, Berkeley, Berk…
Förderung
- Arc Institute
- Siebel Scholars Foundation
- Shurl and Kay Curci Foundation
- Rainwater Charitable Foundation
- The Rose Hills Foundation
- Paul and Daisy Soros Fellowships for New Americans
Zitieren
APA
Chandrasekaran, S. S., Tau, C., Fu, B. X. H., Nemeth, M., Bartie, L., Pawluk, A., Konermann, S., & Hsu, P. D. (2026). Rewriting endogenous human transcripts with dual CRISPR-guided 3′ trans-splicing. Cell Systems. https://doi.org/10.1016/j.cels.2025.101487
Vancouver
Chandrasekaran SS, Tau C, Fu BXH, Nemeth M, Bartie L, Pawluk A, et al. Rewriting endogenous human transcripts with dual CRISPR-guided 3′ trans-splicing. Cell Systems. 2026. doi:10.1016/j.cels.2025.101487
BibTeX
@article{Chandrasekaran2026,
author = {Chandrasekaran, Sita S and Tau, Cyrus and Fu, Becky Xu Hua and Nemeth, Matthew and Bartie, Liam and Pawluk, April and Konermann, Silvana and Hsu, Patrick D},
title = {Rewriting endogenous human transcripts with dual CRISPR-guided 3′ trans-splicing},
journal = {Cell Systems},
year = {2026},
doi = {10.1016/j.cels.2025.101487}
}
EUVIMED